Companies · BBIO · Pharmaceutical Preparations

BridgeBio Pharma, Inc. (BBIO)

Every material event, decoded in plain English — what each one means for the stock.

Aug 17, 2026$390M secondary offering

A $390M BridgeBio share sale raises cash—for KKR, not BridgeBio

Attruby sales surged and pipeline advanced, but EPS missed expectations

Open live on AllSight — the whole market, decoded →